Related Experiment Video
Updated: Oct 6, 2025

Studying Neurobehavioral Effects of Environmental Pollutants on Zebrafish Larvae
Published on: February 5, 2020
The Cyanotoxin 2,4-DAB Reduces Viability and Causes Behavioral and Molecular Dysfunctions Associated with
Rubia M Martin1, Michael S Bereman1, Kurt C Marsden2
1Department of Biological Sciences, North Carolina State University, Raleigh, NC, USA.
Abstract:
Exposure to cyanotoxins has been linked to neurodegenerative diseases, including amyotrophic lateral sclerosis, Alzheimer's, and Parkinson's disease. While the cyanotoxin β-methylamino-L-alanine (BMAA) has received much attention, cyanobacteria produce many cyanotoxic compounds, several of which have been detected in nature alongside BMAA, including 2,4-diaminobutyric acid (2,4-DAB) and N-(2-aminoethyl)glycine (AEG). Thus, the question of whether 2,4-DAB and AEG also cause neurotoxic effects in vivo is of great interest, as is the question of whether they interact to enhance toxicity. Here, we evaluate the toxic and neurotoxic effects of these cyanotoxins alone or in combination by measuring zebrafish larval viability and behavior after exposure. 2,4-DAB was the most potent cyanotoxin as it decreased larval viability by approximately 50% at 6 days post fertilization, while BMAA and AEG decreased viability by just 16% and 8%, respectively. Although we only observed minor neurotoxic effects on spontaneous locomotion, BMAA and AEG enhanced acoustic startle sensitivity, and they interacted in an additive manner to exert their effects. 2,4-DAB; however, only modulated startle kinematics, an indication of motor dysfunction. To investigate the mechanisms of 2,4-DAB's effects, we analyzed the protein profile of larval zebrafish exposed to 500 µM 2,4-DAB at two time points and identified molecular signatures consistent with neurodegeneration, including disruption of metabolic pathways and downregulation of the ALS-associated genes SOD1 and UBQLN4. Together, our data demonstrate that BMAA and its isomers AEG and 2,4-DAB cause neurotoxic effects in vivo, with 2,4-DAB as the most potent of the three in the zebrafish model.
Insights
Cyanotoxins like BMAA, 2,4-DAB, and AEG are linked to neurodegenerative diseases. This study shows 2,4-DAB is the most potent, causing significant zebrafish larval death and motor dysfunction, while BMAA and AEG also exhibit neurotoxic effects.
Area of Science:
- Environmental toxicology
- Neuroscience
- Molecular biology
Background:
- Cyanotoxins, including beta-methylamino-L-alanine (BMAA), are associated with neurodegenerative diseases.
- Other cyanotoxins like 2,4-diaminobutyric acid (2,4-DAB) and N-(2-aminoethyl)glycine (AEG) coexist with BMAA in nature.
- The neurotoxic potential and synergistic effects of 2,4-DAB and AEG remain largely unexplored.
Purpose of the Study:
- To evaluate the toxic and neurotoxic effects of BMAA, 2,4-DAB, and AEG in vivo.
- To investigate potential additive or synergistic interactions between these cyanotoxins.
- To elucidate the molecular mechanisms underlying 2,4-DAB-induced neurotoxicity.
Main Methods:
- Zebrafish larvae were exposed to varying concentrations of BMAA, 2,4-DAB, and AEG.
- Larval viability and behavioral responses (spontaneous locomotion, acoustic startle) were assessed.
- Proteomic analysis was performed on zebrafish larvae exposed to 2,4-DAB to identify molecular signatures of neurodegeneration.
Main Results:
- 2,4-DAB demonstrated the highest toxicity, reducing larval viability by approximately 50%.
- BMAA and AEG showed lower toxicity but enhanced acoustic startle sensitivity, acting additively.
- 2,4-DAB modulated startle kinematics, indicating motor dysfunction, and proteomic analysis revealed disrupted metabolic pathways and downregulated ALS-associated genes (SOD1, UBQLN4).
Conclusions:
- BMAA, 2,4-DAB, and AEG exert in vivo neurotoxic effects.
- 2,4-DAB is the most potent cyanotoxin among the three tested in the zebrafish model.
- The findings highlight the potential risks of co-exposure to multiple cyanotoxins and implicate 2,4-DAB in neurodegenerative processes.

